InterventionsHuman trial

Semaglutide Improves Postprandial Glucose Metabolism after Spinal Cord Injury: A First Mechanistic Study

ADA Scientific Sessions 2026 Abstract

The paper

ALAMDARI A, HOEKSTRA S, GASTALDELLI A et al.

ADA Scientific Sessions 2026 Abstract · 5 Jun 2026

Presented at ADA Scientific Sessions 2026 · Late-breaking 2822-LB

doi.org/10.2337/db26-2822-lb

Semaglutide may protect kidneys by reducing vascular resistance
Nature Medicine · 4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
The New England Journal of Medicine · 4 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Diabetes & Vascular Disease Research · 4 Oct 2026
SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes
Clinical Journal of the American Society of Nephrology · 4 Oct 2026